(Q52590838)

4 May 2018

title

Venom immunotherapy induces monocyte activation. (English)

1 reference

4 May 2018

1 reference

6

1 reference

4 May 2018

author name string

Magnan A

1

1 reference

4 May 2018

Marin V

2

1 reference

4 May 2018

Mély L

3

1 reference

4 May 2018

Birnbaum J

4

1 reference

4 May 2018

Romanet S

5

1 reference

4 May 2018

Vervloet D

7

1 reference

4 May 2018

publication date

1 August 2001

1 reference

4 May 2018

Clinical & Experimental Allergy

published in

1 reference

4 May 2018

volume

31

1 reference

4 May 2018

issue

8

1 reference

4 May 2018

page(s)

1303-1309

1 reference

4 May 2018

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Mechanisms of allergen-specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Role of interleukin 10 in specific immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Interleukin-12 as a target for modulation of the inflammatory response in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Rapid Hymenoptera venom immunotherapy: comparative safety of three protocols.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Interleukin-12 inhibits antigen-induced airway hyperresponsiveness in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Interleukin-10: an anti-inflammatory cytokine with therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2222.2001.01171.X

10.1046/J.1365-2222.2001.01171.X

21 January 2018

Identifiers

DOI

1 reference

4 May 2018

1 reference

4 May 2018